Print

Purpose

The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults in the age group 18-65 years - Able to read and understand English - Able to provide informed consent - Diagnosed with HIV - History of current or previous Methamphetamine Use Disorder - Endorse craving for methamphetamine - Demonstrate an attentional bias for methamphetamine

Exclusion Criteria

  • Traumatic brain injury - h/o seizure disorder - h/o or current diagnosis of schizophrenia - intracranial metal shrapnel - previous adverse effects with TMS - sub-threshold consistency while performing behavioral tasks - lack of attentional bias to methamphetamine cues - a positive pregnancy test for female participants

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Within participant design with a randomized sequence of interventions.
Primary Purpose
Treatment
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Other
Group 1
Group 1 will receive actual TMS (iTBS and cTBS) on days 2 and 3 and sham TMS on day 4.
  • Device: intermittent theta burst stimulation (iTBS)
    iTBS is an excitatory TMS paradigm that delivers 1800 pulses to the left dlPFC. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: continuous theta burst stimulation (cTBS)
    cTBS is an inhibitory TMS paradigm that delivers 1800 pulses to the frontal pole. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: Sham TMS
    Sham TMS delivered with the MagVenture B65 A/P coil
Other
Group 2
Group 2 will receive actual TMS (iTBS and cTBS) on days 2 and 4 and sham TMS on day 3.
  • Device: intermittent theta burst stimulation (iTBS)
    iTBS is an excitatory TMS paradigm that delivers 1800 pulses to the left dlPFC. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: continuous theta burst stimulation (cTBS)
    cTBS is an inhibitory TMS paradigm that delivers 1800 pulses to the frontal pole. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: Sham TMS
    Sham TMS delivered with the MagVenture B65 A/P coil
Other
Group 3
Group 3 will receive sham TMS on day 2 and actual TMS (iTBS and cTBS) on days 3 and 4.
  • Device: intermittent theta burst stimulation (iTBS)
    iTBS is an excitatory TMS paradigm that delivers 1800 pulses to the left dlPFC. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: continuous theta burst stimulation (cTBS)
    cTBS is an inhibitory TMS paradigm that delivers 1800 pulses to the frontal pole. Participants will receive 2 iTBS sessions separated by 50 minutes.
  • Device: Sham TMS
    Sham TMS delivered with the MagVenture B65 A/P coil

Recruiting Locations

UK Center for Clinical and Translational Science and nearby locations

UK Department of Psychiatry
Lexington, Kentucky 40509
Contact:
Annette Garth, CRC
859-382-7611
annette.garth@uky.edu

More Details

NCT ID
NCT06830980
Status
Recruiting
Sponsor
Gopalkumar Rakesh

Study Contact

Patricia Garth, CRC
859-382-7611
psych_research@uky.edu, annette.garth@uky.edu

Detailed Description

The investigators will compare how two theta burst paradigms, intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS), compare with sham TMS in changing methamphetamine craving and brain activity. iTBS, cTBS, and sham TMS will be delivered in an accelerated fashion (two sessions daily, separated by 50 minutes). iTBS will be delivered to the left dorsolateral prefrontal cortex (left dorsolateral prefrontal cortex), and cTBS will be delivered to the frontal pole. A brain MRI scan will be done before and after the iTBS/cTBS/sham TMS sessions. The study involves four visits. Each visit will last three hours. Hence, participants will spend a total of 12 hours in the study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.